Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2023

Open Access 01-12-2023 | Antibiotic | Matters Arising

Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia

Authors: Yanfei Shen, Xinfang Xie

Published in: Critical Care | Issue 1/2023

Login to get access

Excerpt

To the Editor, …
Literature
1.
Foucrier A, Dessalle T, Tuffet S, Federici L, Dahyot-Fizelier C, Barbier F, Pottecher J, Monsel A, Hissem T, Lefrant JY, et al. Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial. Crit Care. 2023;27(1):211.CrossRefPubMedPubMedCentral
2.
Martin-Loeches I, Leone M, Einav S. Antibiotic stewardship: dead bugs do not mutate. J Transl Int Med. 2022;10(4):290–3.CrossRefPubMed
3.
Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med. 2007;35(8):1888–95.CrossRefPubMed
4.
Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005;11(Suppl 4):17–32.CrossRefPubMed
5.
Huh K, Chung DR, Ha YE, Ko JH, Kim SH, Kim MJ, Huh HJ, Lee NY, Cho SY, Kang CI, et al. Impact of difficult-to-treat resistance in gram-negative bacteremia on mortality: retrospective analysis of nationwide surveillance data. Clin Infect Dis. 2020;71(9):e487–96.PubMed
Metadata
Title
Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia
Authors
Yanfei Shen
Xinfang Xie
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2023
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-023-04656-7

Other articles of this Issue 1/2023

Critical Care 1/2023 Go to the issue

Research

Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies

Perspective

“THE MANTLE” bundle for minimizing cerebral hypoxia in severe traumatic brain injury

Correspondence

Improving frailty assessment: the task is not finished

Correspondence

Large language models and the perils of their hallucinations

Research

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19

Research

Telemedical support for prehospital emergency medical service in severe emergencies: an open-label randomised non-inferiority clinical trial